Home/Filings/4/A/0001181431-12-053346
4/A//SEC Filing

Robinson Murray O. 4/A

Accession 0001181431-12-053346

CIK 0001325879other

Filed

Oct 2, 8:00 PM ET

Accepted

Oct 3, 4:29 PM ET

Size

7.0 KB

Accession

0001181431-12-053346

Insider Transaction Report

Form 4/AAmended
Period: 2012-09-28
Robinson Murray O.
SVP, Translational Medicine
Transactions
  • Exercise/Conversion

    Common Stock

    2012-09-28$2.00/sh+37,500$75,000142,318 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2012-09-2837,5000 total
    Exercise: $2.00Exp: 2016-02-09Common Stock (37,500 underlying)
Footnotes (2)
  • [F1]The amount of securities beneficially owned following reported transaction was incorrectly reported on the reporting person's Form 4 filed on October 2, 2012. The amount has been revised to include 573 shares acquired under the AVEO employee stock purchase plan on June 30, 2012.
  • [F2]This option is fully vested as of February 9, 2010.

Issuer

AVEO PHARMACEUTICALS INC

CIK 0001325879

Entity typeother

Related Parties

1
  • filerCIK 0001551910

Filing Metadata

Form type
4/A
Filed
Oct 2, 8:00 PM ET
Accepted
Oct 3, 4:29 PM ET
Size
7.0 KB